Adverse side effects of recently approved Alzheimer’s therapy, lecanemab, are ‘manageable’, reported a new study published in JAMA Neurology. The findings may inform discussions about the risks of…
Adverse side effects of recently approved Alzheimer’s therapy, lecanemab, are ‘manageable’, reported a new study published in JAMA Neurology. The findings may inform discussions about the risks of…